Increased AAA-TOB3 correlates with lymph node metastasis and advanced stage of lung adenocarcinoma
Post author correction
Article Type: ORIGINAL RESEARCH ARTICLE
Article Subject: Diagnostic Biomarkers
AuthorsYanfeng Liu, Lina Bu, Wei Li, Wei Wu, Shengyu Wang, Xin Diao, Jing Zhou, Guoan Chen, Shuanying Yang
This study was to investigate the differential mitochondrial protein expressions in human lung adenocarcinoma and provide preliminary data for further exploration of the carcinogenic mechanism.
Total proteins of A549 and 16HBE mitochondria were extracted through 2D polyacrylamide gel electrophoresis (2-DE). The differential mitochondria proteins were identified by liquid chromatography–tandem mass spectrometry (LC-MS/MS) and were further confirmed by Western blot, immunoelectron microscopy and immunohistochemistry (IHC) in A549 cells as well as lung adenocarcinoma tissues.
A total of 41 differentially expressed protein spots were found in A549 mitochondria. Of them, 15 proteins were highly expressed and 26 proteins were lowly expressed in the mitochondria of A549 (by more than 1.5 times). Among the 15 more highly expressed proteins, AAA-TOB3 (by more than 3 times) was highly expressed in the mitochondria of A549 compared with the 16HBE, by LC-MS/MS identification. High electron density and clear circular colloidal gold-marked AAA-TOB3 particles were observed in the A549 cells via immunoelectron microscopy. Besides, AAA-TOB3 was confirmed to be elevated in lung adenocarcinoma by Western blot and IHC. Moreover, increased AAA-TOB3 correlated with lymph node metastasis and advanced stage of lung adenocarcinoma (p<0.05).
AAA-TOB3 was highly expressed in lung adenocarcinoma, and the up-regulation of AAA-TOB3 correlated with lymph node metastasis and advanced stage of lung adenocarcinoma, which suggested that it could serve as a potential molecular marker for lung adenocarcinoma.
- • Accepted on 27/04/2017
- • Available online on 15/06/2017
This article is available as full text PDF.
- Liu, Yanfeng [PubMed] [Google Scholar] 1, 2
- Bu, Lina [PubMed] [Google Scholar] 1
- Li, Wei [PubMed] [Google Scholar] 1
- Wu, Wei [PubMed] [Google Scholar] 2
- Wang, Shengyu [PubMed] [Google Scholar] 2
- Diao, Xin [PubMed] [Google Scholar] 2
- Zhou, Jing [PubMed] [Google Scholar] 2
- Chen, Guoan [PubMed] [Google Scholar] 3
- Yang, Shuanying [PubMed] [Google Scholar] 1, * Corresponding Author (firstname.lastname@example.org; email@example.com)
Department of Respiratory Medicine, The Second Affiliated Hospital, Xi’an Jiaotong University, Xi’an - PR China
Department of Respiratory Medicine, The First Affiliated Hospital of Xi’an Medical University, Xi’an - China
Department of Thoracic Surgery, University of Michigan Medical School, Ann Arbor, Michigan - USA